Cargando…
In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy
Until the recent development of disease-modifying therapeutics, spinal muscular atrophy (SMA) was considered a devastating neuromuscular disease with a poor prognosis for most affected individuals. Symptoms generally present during early childhood and manifest as muscle weakness and progressive para...
Autores principales: | Ojala, Kristine S., Reedich, Emily J., DiDonato, Christine J., Meriney, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915832/ https://www.ncbi.nlm.nih.gov/pubmed/33562482 http://dx.doi.org/10.3390/brainsci11020194 |
Ejemplares similares
-
Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future
por: McGrattan, Katlyn Elizabeth, et al.
Publicado: (2021) -
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
por: Glascock, Jacqueline, et al.
Publicado: (2023) -
A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy
por: Keil, Jeffrey M, et al.
Publicado: (2014) -
Infantile spinal muscular atrophy — the potential for cure of a fatal disease
por: Volpe, J. J.
Publicado: (2021) -
Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)